ME/CFS Science @mecfsscience.org · 17/12/20251) Prof. Scheibenbogen announced that the biopharma company Sanofi is willing to support a drug trial on ME/CFS led by the Charité. Sanofi also expressed an interest in gaining a better understanding of the disease and its mechanisms. 17525
ME/CFS Science @mecfsscience.org · 17/12/20252) Not entirely sure which drug this refers to, but Scheibenbogen previously talked about doing a trial targeting plasma cells that produce antibodies, so it could be Isatuximab (which targets the cell marker CD38, the same as Daratumumab). 2202
